Taxotere® Litigation: Ohio Breast Cancer Survivor Now Takes On Sanofi-Aventis

Pharmaceutical litigation

Temporary hair loss following chemotherapy is hard enough. Unfortunately, as acknowledged by the FDA, cases of permanent hair loss (alopecia) have been reported in patients who have been given the chemotherapy drug, Taxotere®. Now a breast cancer survivor from Ohio, Hattie Carson, has decided to take on Sanofi-Aventis in Ohio Federal Court. According to her complaint, Ms. Carson underwent…

Read More